This inventor holds 2 USPTO granted patents and 1 published patent application. Top assignee: Boehringer Ingelheim International Gmbh. Active years: 2004-2007.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2004-2007
Title: Innovations by Xiaohui Mei in Hepatitis C Treatment
Introduction
Xiaohui Mei is a notable inventor based in Highland Mills, NY (US), recognized for his contributions to the field of pharmaceutical compositions targeting hepatitis C. With a total of 2 patents, his work focuses on developing effective treatments for hepatitis C viral infections.
Latest Patents
Xiaohui Mei's latest patents include innovative pharmaceutical compositions for hepatitis C viral protease inhibitors. The first patent discloses lipid-based systems that comprise the hepatitis C viral protease inhibitor along with at least one pharmaceutically acceptable amine, one pharmaceutically acceptable base, and one pharmaceutically acceptable oil. These compositions are designed to inhibit the replication of the hepatitis C virus (HCV) and provide treatment for HCV infections. The second patent presents improved bioavailability compositions, which include co-solvent systems, lipid-based systems, solid dispersions, and granulations. These formulations also contain the hepatitis C viral protease inhibitor and at least one pharmaceutically acceptable amine, along with optional additional ingredients.
Career Highlights
Xiaohui Mei is currently employed at Boehringer Ingelheim International GmbH, where he continues to advance his research in pharmaceutical innovations. His work has significantly contributed to the development of effective treatments for hepatitis C, showcasing his expertise in the field.
Collaborations
Xiaohui Mei collaborates with talented coworkers, including Shirlynn Chen and Zeren Wang, who contribute to the innovative research environment at Boehringer Ingelheim.
Conclusion
Xiaohui Mei's contributions to hepatitis C treatment through his patented innovations highlight the importance of research in pharmaceutical sciences. His work not only advances medical knowledge but also offers hope for effective treatments for those affected by hepatitis C.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
